Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79671.080.0051%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

C4 Therapeutics Inc (CCCC) Stock Price, Quote, News & History

CCCCNASDAQ
Trade with Public
Trade with Public
$3.76
0.020.53%
At close: Sep 4, 5:00 PM EST
$3.72
-0.0368-0.98%
After Hours: 5:04 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

C4 Therapeutics (CCCC) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$3.72
Close
$3.76
Volume / Avg.
2.36M / 2.95M
Day Range
$3.66 - $3.85
52 Wk Range
1.69 - 5.17
Market Cap
$458.05M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
44
Short Interest
27.84%
Days to Cover
13.93

Recent C4 Therapeutics, Inc. News

Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.
Avi Kapoor

Nasdaq Surges Over 1%; Alibaba Shares Gain After Q4 Results

US stocks mixed, Nasdaq up 200 points. Dow down 0.43%, Nasdaq up 0.79%, S&P 500 up 0.27%. Communication services up 1.6%, utilities down 1.4%. Alibaba shares up 6% after reporting mixed Q4 results. Velo3D up 47%, Wix.com down 30%, National Vision down 25%.
Avi Kapoor

Vishay Intertechnology, Eos Energy Enterprises, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday

Vishay Intertechnology (VSH) stock up 10%, Velo3D (VELO) up 35.5%, VNET (VNET) up 32.5%, C4 Therapeutics (CCCC) up 19.4%, Kingsoft Cloud (KC) up 18.6%, Tower Semiconductor (TSEM) up 17.5%, Nebius Group (NBIS) up 16.6%, Sellas Life Sciences (SLS) up 15.5%, Eos Energy (EOSE) up 14.6%, Nextpower (NXT) up 14.4%.
Avi Kapoor

C4 Therapeutics Deepens Roche Alliance To Target Breakthrough Cancer Therapies

C4 Therapeutics partners with Roche to develop cancer-fighting DACs. CCCC eligible for $1B+ in milestones plus royalties. See the details.
Vandana Singh

This Coca-Cola Femsa Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday

Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-84.87M
Investing Cash Flow (TTM)
-75.31M
Financing Cash Flow (TTM)
160.63M
Free Cash Flow (TTM)
-85.39M
Capital Expenditure (TTM)
-523.00K
Net Change in Cash (TTM)
453.00K

Analyst Trends and Forecast

1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$265.15M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
11.88
PB Ratio (TTM)
1.86
Earnings Yield % (TTM)
-24.40%
Earnings Yield % (FWD)
-24.93%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.01

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$78.61M
Debt to Equity
0.23
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.72
Close
$3.76
Volume / Avg.
2.36M / 2.95M
Day Range
$3.66 - $3.85
52 Wk Range
1.69 - 5.17
Market Cap
$458.05M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
44
Short Interest
27.84%
Days to Cover
13.93

About

Sector
Health Care
Industry
Biotechnology
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targe...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy C4 Therapeutics (CCCC) stock?

A

You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are C4 Therapeutics (CCCC) competitors?

Q

What is the forecast, or price target, for C4 Therapeutics (CCCC) stock?

A

C4 Therapeutics has a consensus price target of $10.83.

Q

What is the current price for C4 Therapeutics (CCCC)?

A

The stock price for C4 Therapeutics (NASDAQ: CCCC) is $3.7232 last updated September 4, 2026 at 5:04 PM EDT.

Q

Does C4 Therapeutics (CCCC) pay a dividend?

A

There are no upcoming dividends for C4 Therapeutics.

Q

When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?

A

C4 Therapeutics does not have any upcoming earnings scheduled.

Q

Is C4 Therapeutics (CCCC) going to split?

A

There is no upcoming split for C4 Therapeutics.

Q

What sector and industry does C4 Therapeutics (CCCC) operate in?

A

C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved